Thursday, September 14, 2017

Eaze Continues Advancing #Cannabis Industry with an Additional $27M Raised

Eaze Continues Advancing #Cannabis Industry with an Additional $27M Raised

Cannabis Technology Pioneer Eaze raises additional capital to support rapid growth

SAN FRANCISCO - September 14, 2017 (Investorideas.com Newswire) Eaze, the leading cannabis technology company, announced today an additional $27 million in Series B financing, led by Bailey Capital with participation from DCM Ventures, Kaya Ventures and FJ Labs. The latest round brings Eaze's total funding to $52 million.
Eaze will use the financing for continued expansion throughout California and other states, to provide safe, convenient and professional access to legal marijuana. James Bailey has also joined the board of directors bringing relevant industry experience as an investor in PAX Labs, High Times and MedMen.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.